• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
Reading the Brain’s Response: Enveric’s EB-003 Takes a Step Toward Human Testing
The Cost of Waiting: What Compass’s Depression Survey Means for Psychedelic Medicine
Beyond the Psychedelic Experience: Enveric Biosciences Takes Another Step Toward a New Generation of Mental Health Treatments
Ibogaine's Momentum Is Real. So Is the Safety Gap Nobody's Solving.
Psychedelic Medicine Is Having an Identity Crisis — And That's a Good Thing
Enveric Biosciences Adds Another Data Point to Its Case That EB-003 Won't Get You High
FDA's New Psychedelic Guidance Signals a Maturing Industry. Now Comes the Hard Part.
The Psychedelic Sector Has Grown Up. Wall Street Just Hasn't Fully Realized It Yet
Medical Psilocybin Act
PTSD, Policy Shifts, and the Rise of Neuroplastogens: What Enveric’s Latest Data Signals for the Field
Shop

John Oliver Covers Psychedelics on Last Week Tonight

Microdose NewsDesk by Microdose NewsDesk
February 22, 2023
in Culture
Reading Time: 1 min read
A A
John Oliver Covers Psychedelics on Last Week Tonight

 

Emmy-award winning talk show host John Oliver has devoted his entire segment to psychedelic therapy.

Combining long-form journalism and satirical comedy, John Oliver’s Last Week Tonight is known for its in-depth looks at important social issues. They’ve won several Emmys for this kind of work, which makes their recent focus on psychedelic therapy big news for advocates and enthusiasts hoping to educate the public about the potential of psychedelics.

The show covered a range of psychedelic topics, from the history of psychedelic research, the War on Drugs, the current renaissance and its impressive trial results, stories of patient healing

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Order Lasix Cheap Online

, and even patent issues.

Continue on your trip...

Childhood Trauma’s Role in Men’s Substance Use Disorders

Human-Centered AI in Healthcare

After the Billion-Dollar Psychedelic Bet: Who’s Next for Big Pharma?

This was another important cultural milestone in destigmatizing psychedelics to mainstream audiences.

See below for the full segment.

 

 

 

For more on celebrities on psychedelics, check out Celebrity Psychedelic Update

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: John Olivermedia
Microdose NewsDesk

Microdose NewsDesk

Microdose's editorial department brings you the latest news and industry insights.

Next Post
Compass Pathways’ New Psilocybin For Depression Trial, Explained

Compass Pathways’ New Psilocybin For Depression Trial, Explained

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

Reading the Brain’s Response: Enveric’s EB-003 Takes a Step Toward Human Testing

The Cost of Waiting: What Compass’s Depression Survey Means for Psychedelic Medicine

Beyond the Psychedelic Experience: Enveric Biosciences Takes Another Step Toward a New Generation of Mental Health Treatments

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.